To all of our partners, well done.
When we work together, we change lives. And our accomplishments become your accomplishments, too.
See how we’re better togetherMeet Our Team
We have built a reputation for taking on high-acuity patients and we are receiving referrals for those patients around the region.
James Tweddell, MD Executive Co-Director of the Heart Institute
See Info
James Tweddell, MD
Executive Co-Director, Heart Institute; Director of Cardiothoracic Surgery 513-803-8824 james.tweddell@cchmc.orgWhat makes us different? Our goal is not to perform the most cases, but to perform the most innovative ones.
See Info
Andrew Redington, MD
Executive Co-Director, Heart Institute; Chief, Pediatric Cardiology andrew.redington@cchmc.orgCincinnati Children's is already one of the leading Children's Hospitals in the world let alone the United States. What really impresses me though, is that that's not enough.
See Info
Jeffrey Robbins, PhD
Executive Co-Director, Heart Institute; Director, Molecular Cardiovascular Biology 513-636-8098 jeffrey.robbins@cchmc.orgWe're all directed towards a single goal – that is to make a difference and cure pediatric heart disease.
See Info
See Info
Gruschen Veldtman, FRCP, MBChB
Director, Adolescent and Adult Congenital Heart Disease 513-803-2243 gruschen.veldtman@cchmc.orgSee Info
Improving Regional Pediatric Heart Care as a Team
We are pushing the field forward with lung assist devices as a way to bridge children to lung transplant and rehabilitate them by getting them extubated, out of bed and well nourished to optimize their post-transplant outcomes.
David L.S. Morales, MD Director, Congenital Heart Surgery
See Info
Angela Lorts, MD
Medical Director, Mechanical Circulatory Support 513-803-4580 angela.lorts@cchmc.orgSee Info
Roosevelt Bryant III, MD
Surgical Director, Pediatric Heart Transplant Program 513-636-4770 roosevelt.bryantIII@cchmc.orgHeart Valve Tissue Engineering: Making Strides
New Transcatheter Valve Further Expands Non-Surgical Pulmonary Valve Replacement Options for Patients
Program Data
This technology would make it possible to predict the eventual cardiac phenotype in pediatric patients and help guide their treatment and future monitoring.
Jeffery D. Molkentin, PhD Professor, Howard Hughes Medical Institute Investigator